GLUCOSE METABOLIC CHANGES DRIVE DISEASE PROGRESSION AND RELAPSE IN RUNX1::ETO ACUTE MYELOID LEUKEMIA

EHA Library, Nuria Tubio Santamaria, 4160508

TARGETING METABOLIC ALTERATIONS IN PML::RARα+ MYELOID CELLS TO OVERCOME RESISTANCE AND RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA.

EHA Library, Nelida I. Noguera, 4160507

COMPLEMENTARITY OF HIGH-THROUGHPUT SEQUENCING AND FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE IN AML: A REAL LIFE STUDY FROM THE HAUTS-DE-FRANCE OBSERVATORY

EHA Library, Augustin Boudry, 4160505

DIRECT FUNCTIONAL HOXA9/DNA BINDING COMPETITORS VERSUS EPIGENETIC INHIBITORS OF HOXA9 EXPRESSION ON CELL PROLIFERATION, DEATH AND DIFFERENTIATION PROCESSES IN THE MODEL OF MLL-REARRANGED ACUTE MYELOID LEUKAEMIA

EHA Library, Marie-Helene David-Cordonnier, 4160504

OVERCOMING AML HETEROGENEITY THROUGH MITOCHONDRIAL ACTIVITY AND AUTOPHAGY-INDUCED ENHANCEMENT OF AML CELLS BY BONE MARROW STROMAL CELLS

EHA Library, Shuqing Wang, 4160501

RGT-61159, A POTENT AND SELECTIVE SMALL MOLECULE MYB RNA INHIBITOR, SHOWED SIGNIFICANT ANTI-TUMOR ACTIVITY AS MONOTHERAPY OR IN COMBINATION WITH STANDARDS OF CARE IN SEVERAL LEUKEMIA DISEASE MODELS HARBORING AML MOST COMMON GENETIC LESIONS

EHA Library, Patricia Soulard, 4160500

IDENTIFICATION OF ELOVL6 AS A CAUSAL FACTOR AND POTENTIAL THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA

EHA Library, Linhui Hu, 4160499

HIGH THROUGHPUT DRUG SCREEN COUPLED TO PROTEO-GENOMIC DATA IDENTIFIES EPIGENETIC VULNERABILITIES IN AML SUBTYPE-SPECIFIC PATIENT GROUP

EHA Library, Shanna Hogeling, 4160495

JAK2 R1063H GERMLINE VARIANT IN AML: ASSOCIATION WITH ONCOGENIC IDH1/2 DRIVERS RESULTING IN COOPERATIVE LEUKEMOGENESIS AND THERAPEUTIC IMPLICATIONS

EHA Library, Katarina Hlusickova Kapralova, 4160494

DISRUPTING MITOCHONDRIAL FUNCTION IN ACUTE MYELOID LEUKEMIA: PERSONALIZED APPROACH TO THERAPEUTIC STRATEGY COMBINING BCL-2 INHIBITION WITH COMPLEX I BLOCKADE

EHA Library, Natalia Baran, 4160490

CD180 IS A TARGETABLE MARKER FOR SENESCENCE ASSOCIATED CHEMORESISTANT IN PAEDIATRIC KMT2A-REARRANGED ACUTE MYELOID LEUKAEMIA

EHA Library, Aya Gouma, 4160489

SYNERGISTIC EFFECTS OF PRL2 AND TKI CO-INHIBITION IN FLT3-MUTATED AND MLL-REARRANGED ACUTE MYELOID LEUKEMIA

EHA Library, Hongxia Chen, 4160488

MICROBIOTA-INSPIRED COMPOUNDS AS NOVEL DRUG CANDIDATES TARGETING NPM1-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Miguel Ángel Navarro Aguadero, 4160486

SINGLE-CELL PROFILING IDENTIFIES LEUKEMIC STEM CELL SUBTYPES LINKED TO ATRA SENSITIVITY IN RAS MUTANT ACUTE MYELOID LEUKEMIA

EHA Library, Diego A Pereira-Martins, 4160484

MAPPING LEUKEMIC STEM CELLS IN PEDIATRIC AML: A MULTIMODAL FRAMEWORK TO PRECISION TARGETING

EHA Library, sina kanannejad, 4160480

GATA2 N-TERMINAL ZINC FINGER DOMAIN MUTATIONS PROMOTE ERYTHROID CLONAL EXPANSION IN ACUTE MYELOID LEUKEMIA

EHA Library, Tianhui Liu, 4160479

TBK1-OPTN INTERACTION PROMOTES AML PROLIFERATION AND VENETOCLAX RESISTANCE BY ACTIVATING MITOPHAGY, TARGETED BY A NOVEL INHIBITOR PEPTIDE

EHA Library, Fan Niu, 4160478

TARGETING O-GLCNAC TRANSFERASE (OGT)-MEDIATED DRUG RESISTANCE IN INV(3)/T(3;3) AML

EHA Library, Junbum Im, 4160476

EPIGENETIC REGULATION OF ALDH1 BY ANTHRACYCLINES DRIVES CHEMORESISTANCE IN AML AND UNVEILS A THERAPEUTIC VULNERABILITY FOR CO-TARGETING WITH DNA METHYLATION INHIBITORS

EHA Library, Mileidys Perez, 4160475

NOVEL EUROFLOW QUALITY ASSESSMENT ON B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA MINIMAL RESIDUAL DISEASE. PROGRAM DEVELOPMENT AND FOUR ROUNDS OF IMPLEMENTATION

EHA Library, Michaela Reiterová, 4160471

OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN STRATIFIED BY BODY MASS INDEX

EHA Library, Wendy Stock, 4160470

REAL-WORLD OUTCOMES OF PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS TREATED WITH A PEDIATRIC-INSPIRED PROTOCOL: A COMPARISON ACROSS TWO TIME PERIODS

EHA Library, Maria Agustina Perusini, 4160468

MRD-BASED TARGET THERAPY FOR PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULT PATIENTS BY THE RALL-2016M PROTOCOL: EFFECTIVE FOR BCP-ALL, SHOWS NO EFFICACY IN T-ALL

EHA Library, Olga Aleshina (Gavrilina), 4160465

VENETOCLAX, TUCIDINOSTAT, PEGASPARGASE, AND DEXAMETHASONE INDUCTION REGIMEN FOR NEWLY DIAGNOSED ADULT ETP-ALL: A CHEMOTHERAPY-FREE, LOW-TOXICITY, EFFECTIVE REGIMEN

EHA Library, Jieping Lin, 4160462

DEFIBROTIDE TREATMENT OUTCOMES IN PATIENTS WITH VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) OCCURRING AFTER EXPOSURE TO INOTUZUMAB (INO) OR GEMTUZUMAB (GO)

EHA Library, Mohamad Mohty, 4160460

T-ACUTE LYMPHOCYTIC LEUKEMIA: NEW PERSPECTIVES ON DIFFERENCES IN IMMUNOPHENOTYPES AND GENE PROFILES BETWEEN CHILDREN AND ADULTS

EHA Library, Siyu Liu, 4160459

TARGETING DNA REPLICATION AND THE INTRA-S-PHASE CHECKPOINT FOR TREATMENT OF TP53-MUTATED AML

EHA Library, Sean Post, 4160502

ACTIVIN A INHIBITION IMPAIRED IN VITRO AML CELL MIGRATION AND IN VIVO BONE MARROW ENGRAFTMENT IN MICE

EHA Library, Blake Moses, 4160503

EFFICACY AND SAFETY OF THE THIRD-GENERATION TYROSINE KINASE INHIBITOR OLVEREMBATINIB IN COMBINATION WITH INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULT PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH RELAPSED DISEASE OR PERSISTENT MINIMAL RESIDUAL DISEASE BRIDGING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PHASE II STUDY

EHA Library, Xiaoyu Zhang, 4160463

GENETIC CHARACTERISTICS OF BCR::ABL1-POSITIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA WITH MULTILINEAGE INVOLVEMENT AND POST-HSCT SURVIVAL ANALYSIS

EHA Library, Tong Wang, 4160464

CLINICAL ANALYSIS OF SEQUENTIAL CAR-T CELL THERAPY COMBINED WITH VENETOCLAX, HYPOMETHYLATING AGENTS, AND PERSONALIZED TARGETED DRUGS IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA

EHA Library, Zhao defeng, 4160466

PROGNOSTIC CLASSIFICATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: INTEGRATED ANALYSIS OF CLINICAL AND GENETIC FEATURES

EHA Library, Kana Kato, 4160467

COMBINATION OF VENETOCLAX AND DARATUMUMAB PLUS CAG REGIMEN IS AN EFFECTIVE TRANSPLANT BRIDGING REGIMEN IN ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH POSITIVE MINIMAL RESIDUAL DISEASE

EHA Library, Li-Jun Peng, 4160469

CO-OCCURRENCE OF CHILDHOOD ACUTE LEUKEMIA AND TYPE 1 DIABETES MELLITUS: A FINNISH CASE-CONTROL STUDY

EHA Library, Julia Ventelä, 4160473

TARGETING MUTANT TP53 ACUTE MYELOID LEUKEMIA THROUGH DISRUPTION OF MYC-GSPT1 AXIS

EHA Library, Michael Andreeff, 4160474

CHARACTERIZATION OF A NOVEL MOLECULAR DEPENDENCY IN HOXA9/MEIS1+ ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Federica Valigi, 4160477

SINGLE-CELL DISSECTION OF SELF-DERIVED VERSUS DONOR-DERIVED T-CELL EXHAUSTION IN BONE MARROW NICHES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Chunzi Yu, 4160481

CXCR4 EXPRESSION IN AML BLASTS AND ITS IMPACT ON CXCR4 INHIBITOR EFFICACY DURING CONSOLIDATION THERAPY: RESULTS FROM THE SAL BLAST TRIAL

EHA Library, Enise Ceran, 4160482

MITOLEUK SCORE: MITOCHONDRIAL GENOME VARIANTS AS A PROGNOSTIC CLASSIFIER FOR ACUTE MYELOID LEUKEMIA COMPLEMENTARY TO EUROPEAN LEUKEMIANET CLASSIFICATION

EHA Library, Julie Mondet, 4160483

PEDIATRIC AML BLASTS PROMOTE AN IMMUNOSUPPRESSIVE M2-LIKE PHENOTYPE BY REPROGRAMMING MACROPHAGE METABOLISM.

EHA Library, Alicia Perzolli, 4160485

DEEP IMMUNOPHENOTYPING BY MASS CYTOMETRY ELUCIDATES THE PROGENITOR TRAJECTORY OF ERYTHROID-DERIVED ACUTE MYELOID LEUKEMIA

EHA Library, Inga KF Motzfeldt, 4160487

OXPHOS-DRIVEN M2-POLARIZED MACROPHAGES SUPPORT LEUKEMIC CELL GROWTH THROUGH MITOCHONDRIAL TRANSFER

EHA Library, Wendy Boschloo, 4160491

ONCOGENIC ASPP2K IN ACUTE MYELOID LEUKEMIA (AML): A POTENTIAL PREDICTIVE MARKER AND NOVEL THERAPEUTIC TARGET

EHA Library, Kerstin Kampa-Schittenhelm, 4160492

MANNOSE METABOLISM INHIBITION IS TOXIC TOWARDS ACUTE MYELOID LEUKAEMIA STEM CELLS WHILE SPARING NORMAL HAEMATOPOIETIC CELLS AT STEADY STATE.

EHA Library, Samantha Mason, 4160493

DRUG PERSISTENCE TO RESISTANCE EVOLUTION ANALYSIS IN HUMAN LEUKEMIA REVEALS DIVERSE LEUKEMIA-INITIATING CELL PHENOTYPES

EHA Library, Michael Milyavsky, 4160496

DECODING ACUTE MYELOID LEUKAEMIA: INTEGRATING FUNCTIONAL PHENOTYPES WITH GENOMICS

EHA Library, Prasad Iyer, 4160497

P16INK4A SUPPRESSION BY FLT3-ITD ENHANCES AML PROGRESSION: MECHANISTIC INSIGHTS AND THERAPEUTIC TARGETING OF EPIGENETIC REGULATORS

EHA Library, jiarui zheng, 4160498

THE TRANSCRIPTIONAL LANDSCAPE OF CLONAL AND MICROENVIRONMENT CELLS IN ACUTE MYELOID LEUKEMIA TREATED WITH HMA-VENETOCLAX AT SINGLE CELL LEVEL

EHA Library, Alfredo Marchetti, 4160506

IDENTIFICATION, EVALUATION AND IN VITRO VALIDATION OF IMMUNOGENIC NEOEPITOPES PREDICTED FROM ACUTE MYELOID LEUKEMIA (AML) BLASTS AFTER EXPOSURE TO SPLICING INHIBITOR DRUGS

EHA Library, Lady Espinosa, 4160509

ASSOCIATION BETWEEN SOCIO-ECONOMIC INEQUALITIES AND HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: ANALYSIS FROM THE GIMEMA-CLARITY STUDY

EHA Library, Francesco Sparano, 4159406

ASSESSMENT OF THE IMPACT OF DEMOGRAPHICS, INFORMATION PROVISION, AND INVOLVEMENT IN TREATMENT DECISION ON LEUKAEMIA PATIENTS' QUALITY OF LIFE: PRIMARY ANALYSIS OF GLOBAL STUDY DATA

EHA Library, Samantha Nier, 4159405

ACQUISITION OF AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AFTER CD19 CAR T CELL TREATMENT IS ASSOCIATED WITH T-CELL DYSFUNCTION AND RESISTANCE IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Chiara F Magnani, 4159182

CHROMATIN HUBS REGULATE CELL IDENTITY AND ONCOGENIC CIRCUITS IN PEDIATRIC T CELL LEUKEMIA

EHA Library, Francesco Boccalatte, 4159183

PRECISION MEDICINE FOR RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA : A FRENCH ALL-TARGET OBSERVATORY REPORT

EHA Library, Aurélie Cabannes-Hamy, 4159186

WHOLE-GENOME SEQUENCING OF 431 PATIENTS REVEALS THE CODING AND NON-CODING MUTATION LANDSCAPES OF PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Kaito Mimura, 4159199

CLINICO-GENOMIC FEATURES OF THERAPY-RELATED MYELOID NEOPLASMS (T-MNS): A NATIONWIDE STUDY

EHA Library, Carmelo Gurnari, 4159200

HIGH-THROUGHPUT BLOOD-BASED PROTEOMIC PROFILING AND SINGLE CELL ANALYSIS REVEAL STROMAL-DERIVED OSMR AS A NOVEL SOLUBLE BIOMARKER HIGHLY PROGNOSTIC OF AML

EHA Library, Hussein Abbas, 4159201

DEVELOPMENT AND INDEPENDENT VALIDATION OF UNSUPERVISED GENOMIC CLASSIFICATION OF PATIENTS WITH ACUTE MYELOID LEUKEMIA USING HIERARCHICAL DIRICHLET MIXTURE MODELS. A HARMONY ALLIANCE STUDY

EHA Library, Amin Turki, 4159225

EARLY RESPONSE PREDICTION BY SINGLE CELL IMMUNE AND SIGNALING PROFILING IN CHRONIC MYELOID LEUKEMIA

EHA Library, Stein-Erik Gullaksen, 4159237

COMPREHENSIVE MOLECULAR CHARACTERIZATION OF TREATMENT-FREE REMISSION AND RELAPSE IN CML PATIENTS: THE EURO-SKI BIOMARKER STUDY

EHA Library, Sebastien Rinaldetti, 4159241

TAFASITAMAB (TAFA) PLUS LENALIDOMIDE (LEN) AND RITUXIMAB (R) FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): RESULTS FROM THE PHASE 3 INMIND STUDY

EHA Library, Marek Trněný, 4159307

EFFICACY OF RITUXIMAB-BENDAMUSTINE WITH OR WITHOUT ACALABRUTINIB IN PATIENTS WITH UNTREATED, HIGH-RISK MANTLE CELL LYMPHOMA: AN ANALYSIS OF THE PHASE 3 ECHO TRIAL

EHA Library, Martin Dreyling, 4159310

COMBINATION TREATMENT WITH NOVEL BCL2 INHIBITOR SONROTOCLAX (BGB-11417) AND ZANUBRUTINIB INDUCES HIGH RATE OF COMPLETE REMISSION FOR PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

EHA Library, Raul Cordoba, 4159311

REAL-WORLD-EVIDENCE IN THE ERA OF EBMT CRITERIA FOR PEDIATRIC SINUSOIDAL OBSTRUCTION SYNDROME AND TREATMENT WITH DEFIBROTIDE: A REPORT FROM JAPANESE NATIONWIDE SURVEY

EHA Library, Hirotoshi Sakaguchi, 4159342

MYELOABLATIVE FRACTIONATED BUSULFAN CONDITIONING REGIMEN WITH SORAFENIB FOR ALLOGENEIC STEM CELL TRANSPLANT IN PATIENTS WITH AML: RESULTS OF A PHASE 1/2 CLINICAL TRIAL

EHA Library, Uday R. Popat, 4159343

ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN AML PATIENTS TREATED WITH AZACITIDINE AND VENETOCLAX : A RETROSPECTIVE MULTICENTER REAL-LIFE STUDY BY FRENCH AURAML GROUP

EHA Library, Urbain Tauveron-Jalenques, 4159344

IMPACT OF HYPOMETHYLATING AGENTS +/- VENETOCLAX FOR THE MANAGEMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC PATIENTS RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A SUBANALYSIS ON 308 PATIENTS OF THE GITMO AML/MDS-RELAPSE REGISTRY STUDY.

EHA Library, Michele Malagola, 4159345

RAVULIZUMAB PLUS BEST SUPPORTIVE CARE TO TREAT PEDIATRIC PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY: FIRST RESULTS FROM A PHASE 3 TRIAL

EHA Library, Michelle Schoettler, 4159346

OUTCOMES OF PERIPHERAL BLOOD STEM CELLS VERSUS BONE MARROW IN ADULT SICKLE CELL DISEASE PATIENTS UNDERGOING HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Maud Zwolsman, 4159362

THE IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ON SICKLE CELL RETINOPATHY AND MACULOPATHY: A PROSPECTIVE, OBSERVATIONAL STUDY

EHA Library, Elisabeth Dovern, 4159365

HYDROXYUREA IMPROVES MESENTERIC BLOOD FLOW AND REDUCES GUT PERMEABILITY IN SICKLE CELL DISEASE MICE

EHA Library, Erica Gotardo Azevedo, 4159366

BURNOUT SYMPTOMS AMONG HEMATOLOGY PROFESSIONALS: AN EHA SURVEY

EHA Library, Côme Bommier, 4159402

METHYLPHENIDATE ALLEVIATES FATIGUE IN HAEMATOLOGICAL CANCER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL - THE MICRO TRIAL

EHA Library, Henrik Frederiksen, 4159404

INVESTIGATING GLOBAL GENDER DEMOGRAPHICS AND EQUITY AMONG HEMATOLOGISTS

EHA Library, Florence Broussais Guillaumot, 4159403

SMALL ACTIVATING RNA-MEDIATED INDUCTION OF HBG VIA LIPOSOME DELIVERY FOR IN VIVO TREATMENT OF SICKLE CELL DISEASE

EHA Library, Bríd Ryan, 4159364

HIGH MORTALITY DUE TO PNEUMOCOCCAL MENINGITIS IN CHILDREN WITH SICKLE CELL DISEASE: A FRENCH MULTICENTER OBSERVATIONAL STUDY FROM 2001 TO 2021.

EHA Library, Inès FAFI, 4159363

MORNINGSUN: OPEN-LABEL PHASE II TRIAL OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS MOSUNETUZUMAB (MOSUN SC) AS FRONTLINE (1L) TREATMENT IN SYMPTOMATIC PATIENTS WITH MARGINAL ZONE LYMPHOMA (MZL)

EHA Library, John M. Burke, 4159309

UPDATED EFFICACY & SAFETY OF THE BRUTON TYROSINE KINASE (BTK) DEGRADER BGB-16673 IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM): ONGOING PHASE (PH) 1 CADANCE-101 STUDY RESULTS

EHA Library, Anna Maria Frustaci, 4159308

DARATUMUMAB OR OBSERVATION FOR MINIMAL RESIDUAL DISEASE REAPPERANCE IN MULTIPLE MYELOMA: RESULTS FROM THE PREDATOR-MRD RANDOMIZED TRIAL

EHA Library, Krzysztof Jamroziak, 4159281

ISATUXIMAB SUBCUTANEOUS VIA AN ON-BODY DELIVERY SYSTEM VERSUS ISATUXIMAB INTRAVENOUS, PLUS POMALIDOMIDE AND DEXAMETHASONE, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE RANDOMIZED PHASE 3 IRAKLIA STUDY

EHA Library, Xavier Leleu, 4159280

LINVOSELTAMAB + CARFILZOMIB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL RESULTS FROM THE LINKER-MM2 TRIAL

EHA Library, Salomon Manier, 4159279

PHASE 2 REGISTRATIONAL STUDY OF ANITOCABTAGENE AUTOLEUCEL FOR RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED RESULTS FROM IMMAGINE-1

EHA Library, Gurbakhash Kaur, 4159278

TALQUETAMAB + CETRELIMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY AND EFFICACY RESULTS FROM THE PHASE 1B TRIMM-3 STUDY

EHA Library, Aurore Perrot, 4159277

SETD2 DEFICIENCY IN CML INDUCES METABOLIC REPROGRAMMING CONTRIBUTING TO DRUG RESISTANCE AND DISEASE PROGRESSION

EHA Library, Manuela Mancini, 4159240

INTEGRATING GENOMIC AND TRANSCRIPTOMIC INSIGHTS FOR PREDICTING RESPONSES AND OUTCOMES IN PATIENTS WITH CML RECEIVING 3RD-GENERATION TKI THERAPY

EHA Library, Xiaoshuai Zhang, 4159239

IMPACT OF MITOCHONDRIAL DNA MUTATIONS ON METABOLIC ADAPTATION AND TYROSINE KINASE INHIBITOR RESPONSE IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Ilaria Stefania Pagani, 4159238

PHASE 3 STUDY OF INTENSIVE CHEMOTHERAPY WITH OR WITHOUT DASATINIB IN PATIENTS WITH CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA - FINAL ANALYSIS OF THE AMLSG 21-13 TRIAL

EHA Library, Hartmut Döhner, 4159226

REAL WORLD OUTCOMES IN A SERIES OF 417 ADULT PATIENTS WITH KMT2A (MLL) GENE REARRANGED ACUTE MYELOID LEUKEMIA

EHA Library, Irene Navarro-Vicente, 4159224

REFINEMENT OF THE ELN2022 PROGNOSTIC SUBGROUPS IN A REAL-LIFE COHORT OF 1747 INTENSIVELY TREATED ADULT AML PATIENTS OF THE PETHEMA REGISTRY

EHA Library, Joaquín Martinez-Lopez, 4159223

MYELOID NEOPLASMS RISKS FOR GERMLINE DDX41 PATHOGENIC VARIANTS CARRIERS

EHA Library, Marie-Charlotte Villy, 4159222

MULTIMODAL ANALYSIS OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS REVEALS ASSOCIATIONS BETWEEN GENETIC LESIONS AND IMMUNOPHENOTYPES

EHA Library, Tim Mocking, 4159198

INTEGRATIVE SPATIAL MULTI-OMICS REVEAL NICHE-SPECIFIC INFLAMMATORY SIGNALING AND DIFFERENTIATION HIERARCHIES IN ACUTE MYELOID LEUKEMIA

EHA Library, Hussein Abbas, 4159197

A GENE EXPRESSION BASED MACHINE LEARNING CLASSIFIER ROBUSTLY IDENTIFIES 20 T-ALL SUBTYPES ACROSS COHORTS AND AGE GROUPS.

EHA Library, Thomas Beder, 4159185

MULTIOMIC AND SINGLE CELL RNA-ANALYSES REVEAL TREATMENT RESISTANT STEM-LIKE CELLS TO DRIVE RELAPSE OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)

EHA Library, Kerstin Rauwolf, 4159184

FIRST-IN-HUMAN STUDY OF JNJ-79635322 (JNJ-5322), A NOVEL, NEXT-GENERATION TRISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL PHASE 1 RESULTS

EHA Library, Rakesh Popat, 4159177

BLOOD-BASED PROTEOMICS FOR DEEPER INSIGHTS INTO INDOLENT SYSTEMIC MASTOCYTOSIS: THE PIONEER TRIAL EXPERIENCE

EHA Library, Yu-An Kuo, 4171792

MINOR INDEPENDENT CLONES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA HAVE A CLL-BIASED BIOLOGICAL SIGNATURE: IMPLICATIONS FOR DISEASE ONTOGENY AND EVOLUTION

EHA Library, Ian Márquez-López, 4159181

BETTER SAFETY AND EFFICACY WITH ROPEGINTERFERON ALFA-2B OVER ANAGRELIDE AS SECOND-LINE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA IN THE TOPLINE RESULTS OF THE RANDOMIZED PHASE 3 SURPASS-ET TRIAL

EHA Library, Harinder gILL, 4159179

POLATUZUMAB VEDOTIN, RITUXIMAB, GEMCITABINE AND OXALIPLATIN (POLA-R-GEMOX) FOR RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): RESULTS FROM THE RANDOMIZED PHASE III POLARGO TRIAL

EHA Library, Matthew Matasar, 4159178

A PHASE 3 RANDOMISED TRIAL OF POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR GVHD PROPHYLAXIS IN MATCHED SIBLING DONOR PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: THE ALLG BM12 CAST TRIAL

EHA Library, David Curtis, 4159180